ConocoPhillips heads into its May 7 Q1 2026 results with a striking split between analyst optimism and insider behaviour that the print will need to reconcile.
The most telling signal is what executives have done with their own shares. CEO Ryan Lance sold over 620,000 shares across two March transactions, collecting roughly $80 million at prices between $127 and $133. The General Counsel and two Executive Vice Presidents followed with additional disposals. Net insider selling over the past 90 days totalled more than $100 million in value. These are not token sales — they represent a consistent, broad-based exit by the leadership team at prices above where the stock trades today at $123.19, which is already down 6.7% over the past month.
Analysts, by contrast, have been lifting targets aggressively. Barclays raised its target to $136 on May 1, keeping an Overweight rating. Wells Fargo moved its target all the way to $183 in early April, and Citigroup, Morgan Stanley, and Piper Sandler all raised their numbers in the weeks prior. The consensus mean target stands at $140.37, implying about 14% upside from current levels. Bulls point to COP's low-cost supply additions in Alaska and EG, free cash flow durability, and relatively clean commodity exposure. Bears are less convinced, citing a Q1 production dip from Winter Storm Fern and the overhang of softer oil prices — revenue fell 5.3% year-on-year in the most recent quarter. The EV/EBITDA multiple has compressed roughly 9% over 30 days to 5.6x, reflecting that softness in the underlying commodity.
Short positioning does not add pressure to the story. Short interest has fallen sharply — down 17.8% over the past month to just 1.5% of the free float — and borrow conditions remain easy, with cost to borrow running below 0.5%. Availability is wide. Peers EOG, CVX, and XOM were all modestly lower on the day alongside COP, so the recent price weakness reflects sector dynamics rather than a company-specific derating. Options positioning is equally calm: the put/call ratio of 0.72 is slightly below its 20-day average, suggesting no unusual demand for downside protection ahead of the release.
The May 7 print will test whether Q1 production came in close enough to full-year guidance — and whether management's capital return language is strong enough to explain why so many of them were selling into the mid-$120s.
See the live data behind this article on ORTEX.
Open COP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
